购物车
- 全部删除
- 您的购物车当前为空
TD-004(HC58-111)是一种新型的间变性淋巴瘤激酶(ALK)融合蛋白降解剂,有效促进ALK蛋白的降解,并抑制ALK融合阳性细胞系SU-DHL-1与H3122的生长,显著减少H3122异种移植模型中的肿瘤生长。
TD-004(HC58-111)是一种新型的间变性淋巴瘤激酶(ALK)融合蛋白降解剂,有效促进ALK蛋白的降解,并抑制ALK融合阳性细胞系SU-DHL-1与H3122的生长,显著减少H3122异种移植模型中的肿瘤生长。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 期货 | |
50 mg | 待询 | 期货 |
产品描述 | TD-004 (HC58-111) is an innovative degrader of anaplastic lymphoma kinase (ALK) fusion proteins, effectively promoting the degradation of ALK proteins. It inhibits the growth of ALK fusion-positive cell lines SU-DHL-1 and H3122, and significantly reduces tumor growth in H3122 xenograft models. |
别名 | TD004, TD 004, HC58-111, HC-58-111, HC58111, HC 58-111 |
分子量 | 1084.78 |
分子式 | C55H70ClN9O8S2 |
CAS No. | 2351915-38-1 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容